Knauf P A, Law F Y, Tarshis T, Furuya W
J Gen Physiol. 1984 May;83(5):683-701. doi: 10.1085/jgp.83.5.683.
External N-(4-azido-2-nitrophenyl)-2-aminoethylsulfonate (NAP-taurine) inhibits human red cell chloride exchange by binding to a site that is distinct from the chloride transport site. Increases in the intracellular chloride concentration (at constant external chloride) cause an increase in the inhibitory potency of external NAP-taurine. This effect is not due to the changes in pH or membrane potential that usually accompany a chloride gradient, since even when these changes are reversed or eliminated the inhibitory potency remains high. According to the ping-pong model for anion exchange, such transmembrane effects of intracellular chloride on external NAP-taurine can be explained if NAP-taurine only binds to its site when the transport site is in the outward-facing (Eo or EClo ) form. Since NAP-taurine prevents the conformational change from EClo to ECli , it must lock the system in the outward-facing form. NAP-taurine can therefore be used just like the competitive inhibitor H2DIDS (4,4'-diisothiocyano-1,2- diphenylethane -2,2'-disulfonic acid) to monitor the fraction of transport sites that face outward. A quantitative analysis of the effects of chloride gradients on the inhibitory potency of NAP-taurine and H2DIDS reveals that the transport system is intrinsically asymmetric, such that when Cli = Clo, most of the unloaded transport sites face the cytoplasmic side of the membrane.
外部的N-(4-叠氮基-2-硝基苯基)-2-氨基乙磺酸盐(NAP-牛磺酸)通过与一个不同于氯离子转运位点的位点结合来抑制人红细胞的氯离子交换。在细胞外氯离子浓度恒定的情况下,细胞内氯离子浓度的增加会导致外部NAP-牛磺酸抑制效力的增加。这种效应并非通常伴随氯离子梯度出现的pH值或膜电位变化所致,因为即使这些变化被逆转或消除,抑制效力仍然很高。根据阴离子交换的乒乓模型,如果NAP-牛磺酸仅在转运位点处于外向型(Eo或EClo)形式时才与其位点结合,那么细胞内氯离子对外部NAP-牛磺酸的这种跨膜效应就可以得到解释。由于NAP-牛磺酸阻止了从EClo到ECli的构象变化,它必定将系统锁定在外向型形式。因此,NAP-牛磺酸可以像竞争性抑制剂H2DIDS(4,4'-二异硫氰酸-1,2-二苯乙烷-2,2'-二磺酸)一样用于监测面向外侧的转运位点的比例。对氯离子梯度对NAP-牛磺酸和H2DIDS抑制效力影响的定量分析表明,转运系统本质上是不对称的,以至于当Cli = Clo时,大多数空载的转运位点面向膜的细胞质一侧。